Using lipidomics and proteomics to find biomarkers that predict progression of multiple sclerosis
This study, in collaboration with the Baker Institute and Walter and Eliza Hall Institute, will examine in a longitudinal study blood samples from people with MS and matched controls, looking for novel lipid and protein biomarkers that can predict the progression of MS.
Identifying such biomarkers is critical to enable appropriate targeting of expensive and potentially toxic pharmaceuticals and invasive medical procedures such as autologous haematopoietic stem cell transplantation to those people with MS whose disease is likely to progress rapidly.
Faculty Research Themes
School Research Themes
For further information about this research, please contact the research group leader.